Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 374

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 16
Chunk 374
---
 ended and at March 31, 2025:

 SCHEDULE
OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT

    (in thousands) 
    Beyond Air  
    Beyond Cancer  
     NeuroNos  
    Total 
  
    Cash, cash equivalents and marketable securities 
    $2,750  
    $2,167  
    $2,000  
    $6,917 
  
    All other assets 
     22,116  
     1,029  
     -  
     23,145 
  
    Total assets 
    $24,866  
    $3,196  
    $2,000  
    $30,062 
  
    Total liabilities 
     (15,082) 
     (589) 
     (50) 
     (15,721)
  
    Net assets 
    $9,784  
    $2,607  
    $1,950  
    $14,341 
  
    Non-controlling interest 
    $-  
    $529  
    $229  
    $758 
  
    Capital expenditures 
    $5,859  
    $24  
    $-  
    $5,883 

    Revenues 
    $3,705  
    $-  
    $-  
    $3,705 
  
    Cost of revenues 
     (5,368) 
     -  
     -  
     (5,368)
  
    Research and development 
     (13,780) 
     (3,062) 
     (15) 
     (16,857)
  
    Selling, general, and administrative 
     (19,565) 
     (6,344) 
     (108) 
     (26,017)
  
    Loss from operations 
     (35,008) 
     (9,406) 
     (123) 
     (44,537)
  
    Interest and finance expense 
     (3,019) 
     -  
     -  
     (3,019)
  
    Other non-operating income/(expense) 
     (1,132) 
     209  
     -  
     (923)
  
    Net loss before income taxes